Seres Therapeutics, Inc. (MCRB) financial statements (2023 and earlier)

Company profile

Business Address 200 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:290,706253,61694,81685,820149,983229,995205,082
Cash and cash equivalents180,002116,04965,12685,82036,08854,53973,933
Short-term investments110,704137,56729,690 113,895138,704131,149
Other undisclosed cash, cash equivalents, and short-term investments     36,752 
Receivables 9,3871,785    
Other undisclosed current assets12,9225,7743,5886,8455,095(31,626)2,528
Total current assets:303,628268,777100,18992,665155,078198,369207,610
Noncurrent Assets
Operating lease, right-of-use asset18,2089,04111,356
Property, plant and equipment17,93813,89719,49526,29432,93136,1257,751
Long-term investments and receivables49549,825   36,752 
Long-term investments49549,825   36,752 
Restricted cash and investments9,4011,4001,4001,5131,5131,4001,539
Other noncurrent assets5,189      
Total noncurrent assets:51,23174,16332,25127,80734,44474,2779,290
TOTAL ASSETS:354,859342,940132,440120,472189,522272,646216,900
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,58411,90510,13814,57615,63615,0499,484
Accounts payable13,7354,0184,8596,4157,0337,5875,397
Accrued liabilities3,6331,1536703,1413,6413,7641,331
Employee-related liabilities9,2166,7344,6095,0204,9623,6982,756
Deferred revenue  4,834
Debt 4544,456    
Due to related parties21,098      
Contract with customer, liability20,419
Other undisclosed current liabilities34,57634,05626,5657,04615,98915,4081,436
Total current liabilities:82,25846,41545,99342,04131,62530,45710,920
Noncurrent Liabilities
Long-term debt and lease obligation42,60135,20040,324    
Long-term debt, excluding current maturities24,64324,63924,648    
Operating lease, liability17,95810,56115,676
Liabilities, other than long-term debt22,0801,0035,336119,2263,3622,072 
Deferred revenue and credits2,2332,072 
Deferred revenue  4,834
Contract with customer, liability116,840
Deferred rent credit   2,216
Due to related parties10,585      
Other liabilities11,4951,0035021701,129  
Other undisclosed noncurrent liabilities76,41385,57289,1117,25093,836107,486586
Total noncurrent liabilities:141,094121,775134,771126,47697,198109,558586
Total liabilities:223,352168,190180,764168,517128,823140,01511,506
Stockholders' equity
Stockholders' equity attributable to parent131,507174,750(48,324)(48,045)60,699132,631205,394
Common stock92917041404039
Additional paid in capital745,829723,482411,255341,284324,376306,931287,937
Accumulated other comprehensive income (loss)(60)(47)  (146)(149)30
Accumulated deficit(614,354)(548,776)(459,649)(389,370)(263,571)(174,191)(82,612)
Total stockholders' equity:131,507174,750(48,324)(48,045)60,699132,631205,394
TOTAL LIABILITIES AND EQUITY:354,859342,940132,440120,472189,522272,646216,900

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues144,92733,21534,50528,26732,10021,766 
Revenue, net32,10021,766 
Revenue from related parties   26,917
Gross profit:144,92733,21534,50528,26732,10021,766 
Operating expenses(209,420)(121,345)(106,381)(128,551)(123,495)(114,605)(54,856)
Operating loss:(64,493)(88,130)(71,876)(100,284)(91,395)(92,839)(54,856)
Nonoperating income (expense)(1,085)(997)1,5971,3422,0151,26076
Investment income, nonoperating2,8709461,033    
Other nonoperating income (expense)(1,045)9811,066170425  
Interest and debt expense(2,910)(446)(502)  (969)(555)
Net loss:(68,488)(89,573)(70,781)(98,942)(89,380)(92,548)(55,335)
Other undisclosed net income attributable to parent2,910446502  969555
Net loss available to common stockholders, diluted:(65,578)(89,127)(70,279)(98,942)(89,380)(91,579)(54,780)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(68,488)(89,573)(70,781)(98,942)(89,380)(92,548)(55,335)
Other comprehensive income (loss)    3(179)30
Comprehensive loss:(68,488)(89,573)(70,781)(98,942)(89,377)(92,727)(55,305)
Other undisclosed comprehensive income, net of tax, attributable to parent2,897399502146 969555
Comprehensive loss, net of tax, attributable to parent:(65,591)(89,174)(70,279)(98,796)(89,377)(91,758)(54,750)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: